Filing Analysis
Bio Essence Corp. has determined that its financial statements for the quarterly period ending March 31, 2024, can no longer be relied upon due to an error in lease accounting. The company incorrectly wrote off a right-of-use asset and lease liability related to an early lease termination that had not been legally finalized with the landlord.
🚩 Red Flags
- Item 4.02 filing: Non-reliance on previously issued financial statements (restatement).
- Accounting error regarding lease termination obligations and right-of-use assets.
- Potential for further scrutiny of internal controls over financial reporting.
📋 Key Facts
- The Company determined on August 19, 2024, that financial statements for the period ending March 31, 2024, are unreliable.
- The error involved the premature write-off of a right-of-use asset and lease liability following an unapproved early lease termination.
- The Company is simultaneously filing an Amended Quarterly Report on Form 10-Q/A to correct these financial statements.
Bio Essence Corp. announced the dismissal of its prior independent accountant, Keith K. Zhen, CPA, and the simultaneous retention of Simon & Edward, LLP as its new principal accountant on August 1, 2024.
🚩 Red Flags
- Auditor change in a micro-cap company often signals underlying friction, even if officially denied by management.
- The dismissal was 'reviewed and recommended' by the Board but not formally approved, suggesting potential governance irregularities or rapid decision-making regarding financial oversight.
📋 Key Facts
- Dismissed former auditor Keith K. Zhen, CPA on August 1, 2024.
- Retained Simon & Edward, LLP (S&E) to serve as the new principal accountant on August 1, 2024.
- The company claims there were no disagreements with the former accountant regarding accounting principles or auditing procedures during the last two fiscal years.
- New auditors will immediately begin finalizing the Q2 2024 financial statements.
Bio Essence Corp. announced the dismissal of its prior independent accountant, Keith K. Zhen, CPA, and the simultaneous retention of Simon & Edward, LLP as its new principal accountant on August 1, 2024.
🚩 Red Flags
- Auditor change in a micro-cap company often warrants scrutiny regarding potential disagreements, despite management's claims to the contrary.
- The dismissal was recommended by the Board but not formally approved, indicating potentially non-standard governance procedures.
📋 Key Facts
- Dismissed Keith K. Zhen, CPA effective August 1, 2024.
- Retained Simon & Edward, LLP to serve as the Company's principal accountant.
- The company claims no disagreements with the former accountant regarding accounting principles or practices.
- Prior financial statements for the last two years did not contain adverse opinions or disclaimers of opinion.
- New auditor (S&E) will immediately begin finalizing Q2 2024 fiscal year financials.
Bio Essence Corp announced the resignation of two directors and the appointment of its CFO, William Sluss, to the Board of Directors. The company also adopted a new Insider Trading Policy.
🚩 Red Flags
- Departure of two board members simultaneously can sometimes signal internal friction, though the company explicitly denied material disputes.
📋 Key Facts
- Yangyang Huang and Simon Shavanson resigned from the Board of Directors effective June 12, 2024.
- Resignations were confirmed on or about June 14, 2024.
- The company stated resignations were not due to any material disputes.
- William Sluss (current CFO) was appointed to the Board of Directors on June 18, 2024.
- An Insider Trading Policy was adopted effective June 21, 2024.
Bio Essence Corp. has completed the sale of its wholly owned subsidiary, Bio Essence Herbal Essentials, Inc., to Health Up, Inc. for a total cash consideration of $400,000.
🚩 Red Flags
- Divestiture of a wholly owned subsidiary for a relatively small amount ($400k) may indicate a need for immediate liquidity or a strategic pivot away from core operations.
- The sale of the primary operating unit (BEP) leaves the parent company as a shell or holding entity, which is common in micro-cap restructuring but carries high risk.
📋 Key Facts
- Transaction Date: Agreement signed March 28, 2024; Closed April 1, 2024.
- Asset Sold: Wholly owned subsidiary Bio Essence Herbal Essentials, Inc. d/b/a Bio Essence Health Science (BEP).
- Buyer: Health Up, Inc. (HUI), a California corporation.
- Consideration: $400,000 in cash.
- Approval: Board of Directors approved via Consent Resolution on March 28, 2024.